| Literature DB >> 30349024 |
Zigui Chen1,2, Yun Kit Yeoh1,2, Mamie Hui1,2, Po Yee Wong1, Martin C W Chan1, Margaret Ip1,2, Jun Yu2,3,4, Robert D Burk5, Francis K L Chan2,3, Paul K S Chan6,7.
Abstract
Studies on the microbial communities in non-human primate hosts provide unique insights in both evolution and function of microbes related to human health and diseases. Using 16S rRNA gene amplicon profiling, we examined the oral, anal and vaginal microbiota in a group of non-captive rhesus macaques (N = 116) and compared the compositions with the healthy communities from Human Microbiome Project. The macaque microbiota was dominated by Bacteroidetes, Firmicutes and Proteobacteria; however, there were marked differences in phylotypes enriched across body sites indicative of strong niche specialization. Compared to human gut microbiota where Bacteroides predominately enriched, the surveyed macaque anal community exhibited increased abundance of Prevotella. In contrast to the conserved human vaginal microbiota extremely dominated by Lactobacillus, the macaque vaginal microbial composition was highly diverse while lactobacilli were rare. A constant decrease of the vaginal microbiota diversity was observed among macaque samples from juvenile, adult without tubectomy, and adult with tubectomy, with the most notable distinction being the enrichment of Halomonas in juvenile and Saccharofermentans in contracepted adults. Both macaque and human oral microbiota were colonized with three most common oral bacterial genera: Streptococcus, Haemophilus and Veillonella, and shared relatively conserved communities to each other. A number of bacteria related to human pathogens were consistently detected in macaques. The findings delineate the range of structure and diversity of microbial communities in a wild macaque population, and enable the application of macaque as an animal model for future characterization of microbes in transmission, genomics and function.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30349024 PMCID: PMC6197227 DOI: 10.1038/s41598-018-33950-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Breakdown of number of samples included in this study.
| Cohort | NCBI SRA | 16S region | Subject # | Sample # | Anal | Oral | Vaginal | ||
|---|---|---|---|---|---|---|---|---|---|
| Female | Male | Female | Male | Female | |||||
| Macaques | PRJNA411767 | V4 | 116 | 314 | 83 | 32 | 83 | 33 | 83 |
| Humans | PRJNA48489 | V3-V5 | 173 | 399 | 70 | 88 | 72 | 96 | 73 |
| Total | 290 | 713 | 153 | 120 | 155 | 129 | 156 | ||
Figure 1Diversity of macaque microbiome comparing with their human counterparts. (A) Alpha diversity of microbiota as measured using the relative inverse Shannon index of genus level 16S rRNA gene phylotypes between macaque and human body sites. (B) Beta diversity of microbiota within and between body sites based on unweighted UniFrac pairwise distances. (C) Principal coordinate plot of unweighted UniFrac distances showing ecological clustering of microbiota by body sites and host species. Asterisks denote significance at *P < 0.05, **P < 0.01 and ***P < 0.001.
Relative abundance of bacteria taxa at the phylum level at the respective body site of macaques and humans.
| Body site | Phylym | Macaque | Human | MW test (p) | LDA score | ||||
|---|---|---|---|---|---|---|---|---|---|
| Abundance$ (%) | Prevalence* (%) | Abundance$ (%) | Prevalence* (%) | Macaque | Human | p value | |||
| Oral | Actinobacteria | 1.11 ± 0.14 | 27.6 | 4.36 ± 0.23 | 94.6 | 1.03E-30 | — | 4.2202 | 1.41E-30 |
| Bacteroidetes | 7.16 ± 0.60 | 94.0 | 23.37 ± 0.67 | 100.0 | 1.31E-35 | — | 4.9048 | 1.78E-35 | |
| Firmicutes | 54.71 ± 1.21 | 100.0 | 42.71 ± 0.85 | 100.0 | 1.04E-13 | 4.7883 | — | 7.84E-14 | |
| Fusobacteria | 5.04 ± 0.43 | 89.7 | 4.88 ± 0.28 | 94.6 | 3.80E-01 | — | — | — | |
| Proteobacteria | 31.66 ± 1.10 | 100.0 | 24.12 ± 0.87 | 100.0 | 4.57E-08 | 4.5592 | — | 6.36E-08 | |
| Spirochaetes | 0.19 ± 0.04 | 2.6 | 0.34 ± 0.05 | 6.5 | 1.16E-02 | — | 2.9318 | 8.79E-03 | |
| Tenericutes | 0.04 ± 0.01 | 0.0 | 0.19 ± 0.04 | 5.4 | 4.57E-01 | — | — | — | |
| Anal | Actinobacteria | 0.37 ± 0.04 | 4.3 | 0.15 ± 0.03 | 2.5 | 2.14E-19 | 3.3448 | — | 3.01E-19 |
| Bacteroidetes | 27.13 ± 1.55 | 97.4 | 69.22 ± 1.40 | 100.0 | 3.95E-37 | — | 5.3210 | 5.45E-37 | |
| Cyanobacteria | 0.17 ± 0.03 | 3.5 | 0.06 ± 0.03 | 2.5 | 3.88E-30 | 3.1827 | — | 6.03E-30 | |
| Elusimicrobia | 0.08 ± 0.06 | 1.7 | 0.00 ± 0.00 | 0.0 | 1.64E-10 | 3.3329 | — | 1.84E-10 | |
| Firmicutes | 34.92 ± 1.61 | 100.0 | 26.77 ± 1.35 | 100.0 | 3.55E-05 | 4.5929 | — | 4.00E-05 | |
| Fusobacteria | 0.23 ± 0.11 | 3.5 | 0.06 ± 0.04 | 1.9 | 2.49E-24 | 3.2631 | — | 3.47E-24 | |
| Proteobacteria | 35.55 ± 2.84 | 100.0 | 2.72 ± 0.26 | 59.5 | 7.59E-37 | 5.2210 | — | 6.37E-37 | |
| Spirochaetes | 0.76 ± 0.07 | 29.6 | 0.00 ± 0.00 | 0.0 | 6.45E-55 | 3.6808 | — | 1.12E-54 | |
| Tenericutes | 0.55 ± 0.11 | 14.8 | 0.62 ± 0.14 | 15.8 | 1.07E-10 | — | 3.3040 | 5.32E-11 | |
| Verrucomicrobia | 0.19 ± 0.03 | 5.2 | 0.38 ± 0.12 | 8.9 | 1.01E-10 | — | 3.3977 | 1.45E-10 | |
| Vaginal | Actinobacteria | 6.53 ± 0.78 | 95.2 | 5.66 ± 1.58 | 30.1 | 1.28E-09 | 3.8415 | — | 2.17E-09 |
| Bacteroidetes | 21.22 ± 1.10 | 100.0 | 4.75 ± 1.14 | 37.0 | 4.71E-19 | 4.9075 | — | 7.85E-19 | |
| Cyanobacteria | 0.03 ± 0.01 | 0.0 | 0.08 ± 0.02 | 1.4 | 5.92E-01 | — | 2.2814 | 4.53E-01 | |
| Firmicutes | 43.68 ± 1.55 | 100.0 | 86.12 ± 2.38 | 100.0 | 2.51E-20 | — | 5.3250 | 4.13E-20 | |
| Fusobacteria | 10.33 ± 1.20 | 84.3 | 0.27 ± 0.14 | 5.5 | 3.03E-22 | 4.6957 | — | 5.11E-22 | |
| Proteobacteria | 13.45 ± 1.07 | 97.6 | 2.70 ± 0.54 | 43.8 | 1.35E-17 | 4.7479 | — | 2.28E-17 | |
| Spirochaetes | 4.56 ± 0.61 | 60.2 | 0.00 ± 0.00 | 0.0 | 3.16E-27 | 4.3492 | — | 5.60E-27 | |
| Synergistetes | 0.00 ± 0.00 | 0.0 | 0.01 ± 0.01 | 1.4 | 2.92E-01 | — | 2.0346 | 2.87E-01 | |
| Tenericutes | 0.15 ± 0.03 | 3.6 | 0.40 ± 0.19 | 6.8 | 2.37E-03 | — | 2.9840 | 1.28E-03 | |
$Mean ± s.e.m.
*Individual samples with >1% abundance were counted.
Figure 2Distribution of microbial taxa between macaque and human body sites. (A) Distribution summarized at the phylum level. The less dominant phyla with mean abundance <1% in any of the respective habitats were combined. (B) Venn diagram showing the number of phyla present in unique or multiple habitat(s). The six phyla with mean abundance >1% in any of respective habitats were counted. (C) Distribution of genera among OTUs within each of three most predominant phyla Firmicutes, Bacteroidetes and Proteobacteria. Genera with <1% mean abundance in the respective habitats are represented by the single group “Others”.
Figure 3The “core” dominant bacterial taxa in each body site of macaques and humans. (A) Heat map showing relative abundances of the dominant taxa in each body site in macaques and humans. Using OTUs summarized at the genus level, a total of 59 “core” bacterial taxa (at the genus, family or higher levels) comprising >1% mean abundance in any of the respective habitats were included. Scale bar represents log2 transformed relative abundance values, with highest value of −0.34 (a log2 of 79%) in red and lowest value of −6.64 (a log2 of 1%) in blue. (B) Venn diagram showing the number of “core” bacterial taxa in each body site of the surveyed macaques (left) and humans (right). (C) Linear discriminant analysis (LDA) for effect size (LEfSe) listing bacterial taxa that best discriminated macaque- (minus values in green) or human-associated microbial communities (positive values in red). A higher LDA score reflects higher relative abundances.
Figure 4Microbial community composition varies between body sites and hosts while predicted metabolic pathways remain stable. Vertical bars represent the relative abundances of microbial taxa summarized at phylum level (denoted by colours) or PICRUSt-predicted KO pathway. Shannon diversity and richness metrics were calculated based on OTUs summarized at the genus level.
Figure 5Distribution of macaque specimens according to gender, age and contraception.
Figure 6Comparison of macaque microbial communities showing the difference of (A) anal microbiota between juvenile and adult male macaques, (B) vaginal microbiota between juvenile and adult female macaques, and (C) vaginal microbiota between adult femal macaque with and without tubectomy. (left) Permutational multivariate analysis of variance (PERMANOVA) using a weighted UniFrac distance, (middle) beta diversity between compared groups, and (right) linear discriminant analysis (LDA) for effect size (LEfSe) listing bacterial taxa that best discriminated defined groups. MWU test, Mann–Whitney U test.
Relative abundance of macaque vaginal bacteria between juvenile, adult without tubectomy, and adult with tubectomy.
| Juvenile (N = 10) | Adult (no tubectomy) (N = 15) | Adult (tubectomy) (N = 58) | Adult (total) (N = 73) | MWU test, p value | Kruskal test | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Abundance$ (%) | Prevalence* (%) | Abundance$ (%) | Prevalence* (%) | Abundance$ (%) | Prevalence* (%) | Abundance$ (%) | Prevalence* (%) | Age^ | Tubectomy# | p value& | |
|
| 0.01 ± 0.01 | 0.0 | 4.62 ± 1.79 | 46.7 | 8.68 ± 0.76 | 82.8 | 7.85 ± 0.73 | 75.3 | 0.0000 | 0.0167 | 0.0000 |
| Prevotellaceae (f) | 0.28 ± 0.12 | 10.0 | 0.57 ± 0.28 | 13.3 | 3.82 ± 0.45 | 75.9 | 3.15 ± 0.39 | 63.0 | 0.0014 | 0.0000 | 0.0000 |
| Lachnospiraceae (f) | 0.43 ± 0.15 | 30.0 | 1.30 ± 0.55 | 26.7 | 3.34 ± 0.47 | 67.2 | 2.92 ± 0.40 | 58.9 | 0.0091 | 0.0086 | 0.0008 |
|
| 0.03 ± 0.01 | 0.0 | 0.67 ± 0.45 | 13.3 | 2.80 ± 0.58 | 56.9 | 2.36 ± 0.48 | 47.9 | 0.0052 | 0.0013 | 0.0001 |
| Peptostreptococcaceae (f) | 0.26 ± ± 0.13 | 10.0 | 0.73 ± 0.26 | 20.0 | 2.03 ± 0.33 | 55.2 | 1.76 ± 0.27 | 47.9 | 0.0010 | 0.0055 | 0.0001 |
|
| 0.02 ± 0.02 | 0.0 | 1.54 ± 0.67 | 40.0 | 2.02 ± 0.25 | 72.4 | 1.92 ± 0.24 | 65.8 | 0.0000 | 0.0282 | 0.0000 |
|
| 0.00 ± 0.00 | 0.0 | 0.85 ± 0.39 | 26.7 | 1.21 ± 0.18 | 39.7 | 1.14 ± 0.16 | 37.0 | 0.0001 | 0.0420 | 0.0000 |
|
| 1.10 ± 0.90 | 10.0 | 0.29 ± 0.17 | 13.3 | 0.06 ± 0.03 | 3.4 | 0.11 ± 0.04 | 5.5 | 0.0006 | 0.0030 | 0.0001 |
|
| 1.23 ± 0.27 | 70.0 | 0.50 ± 0.19 | 26.7 | 0.24 ± 0.09 | 8.6 | 0.29 ± 0.08 | 12.3 | 0.0002 | 0.0321 | 0.0001 |
|
| 1.37 ± 0.34 | 50.0 | 0.50 ± 0.23 | 13.3 | 0.24 ± 0.09 | 5.2 | 0.30 ± 0.08 | 6.8 | 0.0000 | 0.0474 | 0.0000 |
|
| 2.11 ± 0.56 | 70.0 | 1.53 ± 0.84 | 26.7 | 0.56 ± 0.26 | 10.3 | 0.76 ± 0.27 | 13.7 | 0.0001 | 0.0308 | 0.0001 |
|
| 7.33 ± 2.77 | 80.0 | 3.05 ± 1.21 | 46.7 | 1.43 ± 0.64 | 13.8 | 1.77 ± 0.57 | 20.5 | 0.0003 | 0.0127 | 0.0001 |
$mean ± s.e.m.
*Individual samples with > 1% abundance were counted.
^Mann–Whitney U test between juvenile and adult (total) groups.
#Mann–Whitney U test between adult (no tubectomy) and adult (tubectomy) groups.
&Kruskal test test among juvenile, adult (no tubectomy) and adult (tubectomy) groups.